Fig. 1 | British Journal of Cancer

Fig. 1

From: In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells

Fig. 1

CD44 variant 9 (CD44v9) expression in gastric cancer patient-derived cells (PDCs). a CD44 variant 9 (CD44v9) expression in clinical gastric cancer tissues detected by immunohistochemistry (IHC). Expression levels were classified into four levels: non, low, medium and high. Typical staining patterns in each category are shown. b CD44v9 expression levels were scored as described in Supplementary Table 2. The average score in each grade is shown. c Morphologies of the established gastric cancer patient-derived cells (PDCs). d CD44v9-positive cancer cell populations in the gastric cancer PDCs as evaluated by flow-cytometry analysis

Back to article page